BioSpace News Archive

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced that it will participate in the following investor conferences in March.

Coya Therapeutics, Inc. announces that Dr. Alireza Faridar, the Stanley H. Appel Chair in Translational Neuroscience, Stanley H. Appel Department of Neurology at Houston Methodist, will present data showing the contribution of chronic systemic inflammation and dysfunctional Tregs in Frontotemporal Dementia (FTD) patients at the AD/PD 2024 Conference.

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that Kyle Jenne has rejoined Ionis as executive vice president, chief global product strategy officer, to lead all aspects of commercialization at the Company.

AnaptysBio, Inc. today announced that Daniel Faga, president and chief executive officer, will participate in a panel discussion at TD Cowen’s 44th Annual Health Care Conference.

Alamar Biosciences is pleased to announce a strategic supply agreement with ALZpath, a leading developer of diagnostic solutions in Alzheimer’s disease and related dementias.

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will participate in TD Cowen’s 44th Annual Health Care Conference on Wednesday, March 6, 2024, at 11:10 a.m. Eastern Time.

EndoSound™ Inc., a pioneering medical technology company dedicated to advancing patient care, is pleased to announce the appointment of Scott Aldrich Jr as Chief Executive Officer on February 1st, 2024.

Biotricity Inc. proudly announced its Health Canada approval for expansion into the US$1.56 billion Canadian Cardiology Devices market.

Destroy Duchenne, a nonprofit organization founded by DMD patient, Elijah Stacy that aims to Complete the CureTM for Duchenne Muscular Dystrophy (DMD), and DNA Nanobots, a biotechnology leader in DNA nanoparticles engineered for targeted therapeutics, today announced a partnership to develop new targeted non-viral gene therapy technologies for DMD.

Nextech, a leading provider of clinical and administrative healthcare technology solutions for specialty physician practices, today announced clients will be the first to learn about the company’s strategic vision for the future of technology-enabled patient journey innovations at EDGE, its annual user conference.